David Ricks, Eli Lilly CEO (Al Drago/Bloomberg via Getty Images)

Lil­ly CEO rais­es con­cerns about No­vo-Catal­ent buy, call­ing the No­vo Nordisk deal ‘un­usu­al’

Eli Lil­ly has ex­pressed reser­va­tions about the No­vo-Catal­ent deal and its po­ten­tial im­pact on the wider man­u­fac­tur­ing in­dus­try.

“Giv­en the na­ture of this trans­ac­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.